He’s on a winning streak! Jelly Roll revealed he has no plans to slow down his weight loss and exercise habits after dropping 110
Uncategorized
Goodbye Injections? What to Know About the Weight Loss Pills on the Horizon
Popular weight management drugs like Ozempic only come in injectable form, but losing weight may soon be as easy as swallowing a pill. A
Fat Cells Retain a ‘Memory’ of Obesity, Making It Hard to Lose Weight and Keep It Off, Study Suggests
Fat tissue, as seen here under a scanning electron micrograph, maintains a “memory” of obesity, new research suggests. Steve Gschmeissner / Science Photo Library
The IRS has announced 3 key changes to 401(k)s for 2025
Investing in a 401(k) can be one of the best ways to grow your retirement savings. There are lots of reasons why that’s the
Is Investing in Moderna Stock (NASDAQ:MRNA) Simply Dead Money?
Moderna (MRNA) stock has fallen 71% over the last six months. While there’s still potential for near-term revenue tailwinds in the form of emerging
How Much Weight Fluctuation Is Normal?
It’s normal for your weight to go up and down a little each day. Water retention, hormones, medications, what you eat, and how active
6 Reasons Why Weight Gain Can Actually Be Healthier Than Weight Loss, According to Experts
Isabel Vasquez, RD, LDN November 19, 2024 at 2:57 PM Weight loss seems to get all the attention, but there are plenty of cases
Weight loss drug makers still have huge upside, and the market overreacted to RFK Jr. named to top health role, BMO says
Advertisement Shares of obesity drug makers have tumbled since Trump picked RFK Jr. to lead HHS. Investors are fearful Kennedy’s critical stance on the
Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rules
By Jonathan Stempel NEW YORK (Reuters) -A federal judge on Tuesday rejected Pfizer’s bid to recoup about $75.2 million left over from a U.S.
Stock Market Today: Stocks Close Mixed Amid War Angst, Nvidia Anxiety
Stocks slumped as rising geopolitical tensions and anxiety about the state of all things AI sapped the market’s appetite for risk assets. An escalation